Showing results (161-170 of 314) with videos related to
Sort By:
Pageof 32
Journal of the American Society of Nephrology : JASN|May 25, 2001
Parathyroidectomy in patients on renal replacement therapy: an epidemiologic studyFabio Malberti, Daniele Marcelli, Ferruccio Conte, et al.Expert Opinion on Pharmacotherapy|June 28, 2024
Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?Francesco Locatelli, Ernesto Paoletti, Maura Ravera, et al.Journal of Nephrology|January 8, 2024
A novel scenario in the therapeutic management of anemia of chronic kidney disease: placement and use of roxadustatFrancesco Locatelli, Maura Ravera, Ciro Esposito, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 6, 2005
Haemodialysis with on-line monitoring equipment: tools or toys?Francesco Locatelli, Umberto Buoncristiani, Bernard Canaud, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 2004
Hypertension and cardiovascular risk assessment in dialysis patientsFrancesco Locatelli, Adrian Covic, Charles Chazot, et al.Journal of the American Society of Nephrology : JASN|April 15, 2005
Pathochemical toxicity of perfluorocarbon-5070, a liquid test performance fluid previously used in dialyzer manufacturing, confirmed in animal experimentBernard Canaud, Pedro Aljama, Christian Tielemans, et al.Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|April 30, 2014
[Italian adaptation of the European Renal Best Practice (ERBP) guideline on kidney donor and recipient evaluation and perioperative care]Davide Bolignano, Concetta Catalano, Francesco Locatelli, et al.Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|January 10, 2014
[Nephrologist's behaviours and perceptions on sideropenic anemia's diagnosis and treatment for conservative phase nephropatic patient intolerant or not responding to oral iron therapy]Francesco Locatelli, Marcello Amato, Loreto Gesualdo, et al.Clinical Nephrology|June 27, 2012
Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dlWalter H Hörl, Francesco Locatelli, Marianne Haag-Weber, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 18, 2019
Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority TrialFrancesco Locatelli, Thierry Hannedouche, Steven Fishbane, et al.Pageof 32